Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 5Unknown 3Terminated 3Completed 3

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7Tumor-Agnostic 4Genitourinary 4Thoracic 3Head & Neck 3Breast 3NET 2Lymphoid 2Gynecologic 2Endocrine 2CNS 2Other hematologic neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Neoplastic Cells, Circulating 1Lung Neoplasms 1

Interventions

Carboplatin 132Cisplatin 129Pemetrexed 114Docetaxel 81Drug Therapy 62Gefitinib 57anlotinib 55Gemcitabine 55Erlotinib Hydrochloride 55Radiotherapy 48Bevacizumab 48pembrolizumab 47Paclitaxel 47Etoposide 44apatinib 42icotinib 41camrelizumab 39osimertinib 36Nivolumab 33Vinorelbine 31Radiosurgery 30sintilimab 29durvalumab 25aumolertinib 25endostar protein 24atezolizumab 22Endostatins 22toripalimab 19Blood Specimen Collection 19tislelizumab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Positron Emission Tomography Computed Tomography × Thoracic × Clear all
NCT05819905 2023-04-19

Radiomics for prEdiction of lunG cAncer biologY

Poitiers University Hospital

Unknown
600 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03481101 2020-10-08

WHENII

Rigshospitalet, Denmark

Phase NA Unknown
60 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating

NCT04395651 2020-05-20

The Role of 18F-FDG-PET/CT Scan in Lung Cancer Patients

Assiut University

Unknown
30 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡